Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal Method

This publication has 23 references indexed in Scilit:

• High-throughput oncogene mutation profiling in human cancer
  Nature Genetics, 2007
• Rapid and Simple Detection of Hot Spot Point Mutations of Epidermal Growth Factor Receptor, BRAF, and NRAS in Cancers Using the Loop-Hybrid Mobility Shift Assay
  The Journal of Molecular Diagnostics, 2006
• The role of companion diagnostics in the development and use of mutation-targeted cancer therapies
  Nature Biotechnology, 2006
• A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung Cancer
  The Journal of Molecular Diagnostics, 2006
• Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
  Nature Medicine, 2006
• Rapid Detection of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer Using Real-Time Polymerase Chain Reaction with TaqMan-MGB Probes
  The Cancer Journal, 2006
• Detection ofEGFRGene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay
  Clinical Cancer Research, 2006
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004